Table IV.
Change scores in subscales for measurement scale overtime
| Scales | Admission (T0) n = 50 Median (IQR) | Discharge (T1) n = 39 Median (IQR) | z-values^ | p-value* | Effect size (r)# |
|---|---|---|---|---|---|
| ClinFIT (total raw score) (0–300) | 158 (102.5, 195) | 72 (28, 93) | –5.17 | <0.001 | 0.59 |
| ECOG total (0–5) | 0.0 (0, 1) | 1.0 (0, 1) | –3.13 | 0.002 | 0.35 |
| G8SQ (0–17) | 14.0 (10.5, 15) | 13.8 (11, 15) | –0.84 | 0.401 | 0.10 |
| CFS (1–9) | 3.0 (2, 4) | 3 (3, 4) | –0.98 | 0.325 | 0.11 |
| FACT-G total (0–108) | 71 (81.8, 77) | 81 (71, 87) | –3.96 | <0.001 | 0.45 |
| Physical well-being (0–28) | 14 (8.6, 20.3) | 25 (18, 26) | –4.83 | <0.001 | 0.55 |
| Social well-being (0–28) | 24 (24, 26) | 25 (18, 26) | –1.83 | 0.068 | 0.21 |
| Emotional well-being (0–24) | 15 (13, 16) | 14 (12, 15) | –2.34 | 0.019 | 0.26 |
| Functional well-being (0–28) | 19 (12.6, 22) | 20 (15, 24) | –2.03 | 0.042 | 0.23 |
| EQ-5D-5L | |||||
| Mobility (1–5) | 2 (1, 3) | 0 (0, 1) | –4.44 | <0.001 | 0.50 |
| Self-care (1–5) | 3 (1, 4) | 1 (0, 2) | –4.75 | <0.001 | 0.54 |
| Daily activity (1–5) | 3 (2, 4) | 1 (1, 2) | –4.74 | <0.001 | 0.54 |
| Pain/discomfort (1–5) | 2 (1, 4) | 1 (0, 2) | –4.02 | <0.001 | 0.46 |
| Anxiety/depression (1–5) | 1 (0, 2) | 0 (0, 1) | –2.51 | 0.012 | 0.28 |
| Overall health (0–100) | 50 (30, 71) | 75 (65, 85) | –3.89 | <0.001 | 0.44 |
*
Correlation significant at the <0.05 level (2-tailed) are shown in bold.
^
Wilcoxon signed-ranks test.
#
Effect size statistics (r) Cohen’s criteria: 0.2 = small, 0.5 = medium, 0.8 = large effect.
CFS: Clinical Frailty Scale; ClinFIT: Clinical Functioning Information Tool; ECOG: Eastern Cooperative Oncology Group (ECOG) Performance Status scale; EQ-5D: Euro-Quality of life scale; FACT-G: Functional Assessment of Cancer Therapy-General; G8SQ: G8 Screening Questionnaire; IQR: interquartile range; n: total number of participants.